{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T11:16:50Z","timestamp":1763723810934,"version":"3.45.0"},"reference-count":85,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Cardiovascular Therapy"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1586\/erc.12.80","type":"journal-article","created":{"date-parts":[[2012,10,2]],"date-time":"2012-10-02T09:38:07Z","timestamp":1349170687000},"page":"1061-1072","source":"Crossref","is-referenced-by-count":8,"title":["Preventing cardiovascular events with angiotensin II receptor blockers: a closer look at telmisartan and valsartan"],"prefix":"10.1586","volume":"10","author":[{"given":"Massimo","family":"Volpe","sequence":"first","affiliation":[{"name":"Department of Clinical and Molecular Science, Division of Cardiology, Faculty of Medicine, University of Rome Sapienza, Sant\u2019Andrea Hospital, Rome, Italy."},{"name":"IRCCS Neuromed, Pozzilli, Isernia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,1,10]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(01)02321-9"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000165623.72310.dd"},{"key":"e_1_3_2_4_1","first-page":"384","volume":"171","author":"Sciarretta","year":"2011","unstructured":"Sciarretta S, Palano F, Tocci G, Baldini R, Volpe M. Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk. Arch. Intern. Med. 171(5), 384\u2013394 (2011).","journal-title":"Arch. Intern. Med."},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3282fe1d3d"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3280bad9b4"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13501-5"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200001203420301"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14286-9"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69201-5"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/08038020802144383"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08089-3"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp363"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0801317"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60669-2"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032292"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011303"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mnh.0000242175.59823.f2"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005121334"},{"key":"e_1_3_2_20_1","first-page":"S12","volume":"20","author":"Volpe","year":"2007","unstructured":"Volpe M, Tocci G. Therapeutic implications of recent megatrials in hypertension: in favor of new drugs. J. Nephrol. 20(Suppl. 12), S12\u2013S18 (2007).","journal-title":"J. Nephrol."},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16451-9"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0804593"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61193-9"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001121"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010713"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.02.016"},{"key":"e_1_3_2_27_1","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1177\/009127000004001201","volume":"40","author":"Keefe","year":"2000","unstructured":"Keefe DL. Clinical pharmacology of telmisartan. J. Clin. Pharmacol. 40(12 Pt 1), 1311 (2000).","journal-title":"J. Clin. Pharmacol."},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.7.11.1915"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2010.186"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000234122.55895.5b"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3282f35c67"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000236119.96301.f2"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000249692.96488.46"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-11-0059"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042274"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1998"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.204"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn230"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32830508aa"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000024416.33113.0A"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2009.07.018"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61236-2"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.865774"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-1-200907070-00122"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013694"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.864199"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2009.135"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0545"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328338a8b6"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.09.055"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.551143"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-08-0959"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2004.09.005"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02304-5"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.10.026"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.06.001"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.09.033"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.03.105"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.108.541276"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2010.03.004"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.2165\/00151642-200815020-00002"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/0895-7061(95)00043-O"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1992.130"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1097\/00041552-199705000-00009"},{"key":"e_1_3_2_65_1","first-page":"47","volume":"2","author":"White","year":"1997","unstructured":"White WB. Circadian variation of blood pressure: clinical relevance and implications for cardiovascular chronotherapeutics. Blood Press. Monit. 2(1), 47\u201351 (1997).","journal-title":"Blood Press. Monit."},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1177\/147323000002800401"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1177\/147323000903700602"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011161"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61412-9"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09895-1"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp101"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61913-9"},{"key":"e_1_3_2_73_1","first-page":"51","volume":"46","author":"Kotovskaia","year":"2006","unstructured":"Kotovskaia IuV, Kobalava ZhD. [Is primary prevention of arterial hypertension with drugs possible? Results of the TROPHY Study]. Kardiologiia 46(10), 51\u201357 (2006).","journal-title":"Kardiologiia"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200305000-00011"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1586\/14779072.6.9.1195"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011489"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14282-1"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)01187-2"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02213-3"},{"key":"e_1_3_2_80_1","first-page":"80","volume":"49","author":"Preobrazhenksii","year":"2009","unstructured":"Preobrazhenksii DV. [Irbasartan in patients with hart failure and preserved left-ventricular systolic function. Results of the I-PRESERVE study]. Kardiologiia 49(2), 80 (2009).","journal-title":"Kardiologiia"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1577-3"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000166048.35740.a9"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61411-7"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1008816"},{"key":"e_1_3_3_2_1","unstructured":"Diovan\u00ae. Diovan (valsartan) tablets. Prescribing Information. Novartis Pharmaceuticals Corp. NJ USA (2011)."},{"key":"e_1_3_3_3_1","unstructured":"Micardis. Micardis\u00ae (telmisartan) tablets. Prescribing Information. Boehringer Ingelheim International GmbH Ingelheim Germany (2011)."}],"container-title":["Expert Review of Cardiovascular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/erc.12.80","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T11:13:52Z","timestamp":1763723632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1586\/erc.12.80"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":85,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["10.1586\/erc.12.80"],"URL":"https:\/\/doi.org\/10.1586\/erc.12.80","relation":{},"ISSN":["1477-9072","1744-8344"],"issn-type":[{"type":"print","value":"1477-9072"},{"type":"electronic","value":"1744-8344"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}